Jeffrey Hung

Stock Analyst at Morgan Stanley

(0)
# 4250
Out of 5,240 analysts
239
Total ratings
43.30%
Success rate
-8.72%
Average return
42 Stocks
Name Action Price Target Current % Upside Ratings Updated
PTC Therapeutics
Upgrades: Overweight
45 67
43.22 55.02% 10 Dec 13, 2024
Amicus Therapeutics
Downgrades: Equal-Weight
17 12
9.26 29.59% 4 Dec 13, 2024
Bioage Labs
Initiates Coverage On: Overweight
40
n/a n/a 1 Oct 21, 2024
Intra-Cellular Thera...
Maintains: Overweight
92 95
126.73 -25.04% 5 Oct 11, 2024
Centessa Pharmaceuti...
Upgrades: Overweight
11 26
15.4 68.83% 1 Sep 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
40 40
7.58 427.7% 2 Sep 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
28 20
17.11 16.89% 23 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
35
2.12 1550.94% 1 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
160 150
122.63 22.32% 4 Jul 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
160 170
140.08 21.36% 22 Jul 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
50 70
37.06 88.88% 2 May 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
25
13.56 84.37% 1 Apr 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
75 40
59.34 -32.59% 5 Apr 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
55
29.21 88.29% 1 Feb 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
60 90
47.28 90.36% 12 Jan 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
295 330
n/a n/a 3 Dec 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
10 4
1.04 284.62% 10 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
13 4
1.83 118.58% 1 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
29 55
54.37 1.16% 10 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
1 4
0.39 925.64% 1 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
60 140
8.34 1578.66% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
90 84
42.46 97.83% 7 Nov 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
42 40
14.59 174.16% 4 Nov 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
14 14
1.94 621.65% 3 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
5 5
1.72 190.7% 1 Jul 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
9 3
2.21 35.75% 8 Mar 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
15 14
1.3 976.92% 7 Feb 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
42 21
n/a n/a 4 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
27 19
10.01 89.81% 5 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
15
1.97 661.42% 2 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
4 2
n/a n/a 3 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
50 10
2.18 358.72% 3 Jan 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
22 30
n/a n/a 6 Jan 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
23 22
36.33 -39.44% 10 Nov 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
2 2
n/a n/a 5 Sep 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
250 94
n/a n/a 8 Jul 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
146 149
36.74 304.19% 2 May 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
180
n/a n/a 12 Oct 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
100 60
3.83 1466.58% 5 Aug 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
7 6
5.23 14.72% 9 Apr 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
121 225
n/a n/a 9 Oct 6, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
58 54
0.78 6823.08% 6 May 8, 2020